MAM
MED icon

Marquette Asset Management’s Medifast MED Stock Holding History

Marquette Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-30,038
Closed -$319K – 861
2026
Q2 		$319K Buy
+30,038
New +$346K 0.04% 68

Other funds holding MED

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MAFA
MJT & Associates Financial Advisory Monteviceo, Minnesota $155M AUM 15.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Marquette Asset Management's MED Position: Q3 2026 in Review

Marquette Asset Management sold out of Medifast (MED) in Q3 2026, closing a stake of 30,038 shares — an estimated $319K sold.

Marquette Asset Management first reported a position in MED in Q2 2026 and held it in 1 quarter. The position peaked at $319K in Q2 2026. 4 funds tracked by Wall St. Rank hold MED as of Q3 2026.

  • Marquette Asset Management reported no remaining Medifast position as of Q3 2026 after selling out during the quarter.
  • Marquette Asset Management sold 30,038 Medifast shares in Q3 2026, an estimated $319K.
  • Marquette Asset Management first reported a position in Medifast in Q2 2026 and held it in 1 quarter.
  • Marquette Asset Management's Medifast position peaked at $319K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.